Ardena’s expanded nanomedicine facility granted full GMP approval
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full...
adminph
Anthony Harnden
The MHRA has appointed Anthony Harnden as Chair The Medicine and Healthcare products Regulatory Agency (MHRA) has appointed Anthony Harnden,...
New PAGB research highlights importance of self-care for easy-to-treat conditions
The census found that 56% of people visit their GP for a UTI and 27% for thrush New research from...
Siva Anandaciva
The King’s Fund has appointed Siva Anandaciva as Director of Policy, Events and Partnerships The King’s Fund has appointed Siva...
Teva and Immunai partner to improve clinical decision making
The companies will focus on mechanisms of action, dose selection and biomarker analyses Teva Pharmaceuticals and artificial intelligence (AI)-driven Immunai...
Dr Rima Makarem
Somerset NHS Foundation Trust has appointed Dr Rima Makarem as Chair Somerset NHS Foundation Trust has appointed Dr Rima Makarem,...
New drug targets for Alzheimer's identified from cerebrospinal fluid
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the...
Osivax begins phase 2a booster trial for influenza vaccine
First participant vaccinated in study of ovx836 booster dose Osivax, a biopharmaceutical company developing vaccines for broad-spectrum protection against infectious...
AC immune announces positive trial results for early Parkinson’s treatment
Therapy shows high efficacy in initial trial phase AC Immune SA has reported encouraging interim results from its phase 2...
FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment...
Microbiotica begins human trials for ulcerative colitis treatment
First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of...
Vivolta and Neurochase to produce brain therapy catheters
New long-term partnership to address neurological disorder treatments Vivolta, a specialist in medical electrospinning solutions, has entered a long-term partnership...
New weight loss drug target burns energy and lowers appetite – without the nausea and vomiting
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure,...
Lupin to develop near-zero global warming inhalers
Eco-friendly inhalers aim to reduce environmental impact Lupin Healthcare UK Ltd has announced plans to reformulate its pMDI inhalers with...
Infinitopes to showcase cancer vaccine breakthroughs at SITC
Insight into double-blind, phase i/ii clinical trial for oesophageal cancer Infinitopes, an integrated cancer biotech firm, will present its pioneering...
How immune cells “sniff out” pathogens
Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, or...
SMC recommends Yselty for treating uterine fibroids
New treatment option approved for women in Scotland The Scottish Medicines Consortium (SMC) has recommended Yselty (linzagolix) for treating moderate...
Scottish medicines consortium approves CAR T-cell therapy for blood cancer
First car t-cell therapy accepted for second-line treatment in Scotland The Scottish Medicines Consortium (SMC) has approved Kite’s CAR T-cell...
New antibody could be promising cancer treatment
Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody,...
Researchers make glioblastoma cells visible to attacking immune cells
Even treated with the most advanced therapies, patients with glioblastoma - an aggressive brain cancer - typically survive less than...
